Historic Health-Overhaul Bill Passes

Health Industry Winners and Losers

After more than a year of health-overhaul proposals, insurers face changes that will reshape their market, drug-makers claim a victory, hospitals expect to see mixed results and doctors worry about patient loads.

Big Businesses See Little to Cheer

The health-care legislation hits companies in myriad ways, from stricter coverage rules to new taxes, which could change how they offer health care to employees.

How a Troubled Bill Was Revived

The White House revived the health bill vote by vote, using every lever of government at its disposal, after the legislation appeared to be dead.

Order on Abortion Solidifies Support

Antiabortion Democrats extracted a last-minute White House promise Sunday to issue an executive order stating that no federal funds may be used for abortion.

FDA: Not Enough Data on Knee Device

The FDA said ReGen Biologics hasn't provided adequate data to show that its knee device is safe.

FDA Panel Supports Medtronic Pacemaker

An FDA panel recommended the agency approve a Medtronic pacemaker designed to allow patients to undergo an MRI scan.

MRI-Compatible Pacemaker Wins Backing

An advisory panel recommended that the FDA approve a Medtronic pacemaker designed to allow patients to undergo an MRI scan.

Insurers Harden Stance on Rates

Health insurers are fighting demands by hospitals for sharply higher reimbursement rates by threatening to drop the hospitals from their health-plan networks, and blaming them for higher insurance premiums.

GOP Plots to Nullify Health-Care Bill

Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass.

Wavering Voters Walking Highwire

In health debate, pressure mounts on undecided Democratic House members like Indiana's Brad Ellsworth.

• Health-Care Bill's Final Act: A Look at Possible Scenarios

It Costs $940 Billion—and Cuts Deficit?

The health overhaul would cost $940 billion over a decade, yet it would bring down the federal budget deficit by $138 billion, according to the nonpartisan CBO. How is that possible? Mainly new taxes and Medicare spending curbs.

Roche Eyes New Disease Areas

Roche laid out plans to crack a number of new therapy areas—including some, such as schizophrenia and HDL, that other drug companies have backed away from because they found them unpromising.

• The Source: Drugs Are Working for Roche

Democrats Hunt Votes for Health Deal

Democratic leaders are putting heavy pressure on about eight to 10 of key party members who opposed the health-care bill when the House voted last fall.

• Bill Drops Ban on Brand, Generic Deals
• Obama Lobbying Style: All Ears
• Opinion: Health Wars Are Only Beginning
• Tally: Counting the House Votes

FDA Eases Way for Drug Cocktails

The FDA is drawing up guidelines for approving two or more new drugs together to fight deadly diseases such as TB and AIDS.

Bill Drops Ban on Brand, Generic Deals

A proposal that would ban patent-settlements between brand-name pharmaceutical companies and makers of generic medicines won't be included in legislation overhauling the U.S. health-care system.